Related references
Note: Only part of the references are listed.Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders
Sydney Zarriello et al.
PROGRESS IN NEUROBIOLOGY (2019)
Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of alpha-Synuclein Aggregation and ER Stress
Hui-Ju Huang et al.
MOLECULAR NEUROBIOLOGY (2018)
Inhibition of soluble epoxide hydrolase attenuates eosinophil recruitment and food allergen-induced gastrointestinal inflammation
Idil Bastan et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption
M. H. Napimoga et al.
JOURNAL OF PERIODONTAL RESEARCH (2018)
Lipidomic profiling reveals soluble epoxide hydrolase as a therapeutic target of obesity-induced colonic inflammation
Weicang Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease
Qian Ren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia
Ranran Tu et al.
SCIENTIFIC REPORTS (2018)
The Effects of sEH Inhibitor on Depression-like Behavior and Neurogenesis in Male Mice
Qiong Wu et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2017)
Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy
Jiong Hu et al.
NATURE (2017)
Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases
Karen M. Wagner et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Modulation of mitochondrial dysfunction and endoplasmic reticulum stress are key mechanisms for the wide-ranging actions of epoxy fatty acids and soluble epoxide hydrolase inhibitors
Bora Inceoglu et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2017)
Soluble Epoxide Hydrolase Inhibition Protected against Angiotensin II-induced Adventitial Remodeling
Chi Zhou et al.
SCIENTIFIC REPORTS (2017)
Soluble epoxide hydrolase inhibition Promotes White Matter Integrity and Long-Term Functional Recovery after chronic hypoperfusion in mice
Yuxue Chen et al.
SCIENTIFIC REPORTS (2017)
Soluble epoxide hydrolase inhibition alleviates neuropathy in Akita (Ins2 Akita) mice
Karen Wagner et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice
Yong Zhou et al.
CELL AND TISSUE RESEARCH (2016)
Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor
Aili L. Lazaar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Soluble epoxide hydrolase: a new therapeutic target for depression
Kenji Hashimoto
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Discovery of Potent Soluble Epoxide Hydrolase (sEH) Inhibitors by Pharmacophore-Based Virtual Screening
Birgit Waltenberger et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)
Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress
Qian Ren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Anti-Ulcer Efficacy of Soluble Epoxide Hydrolase Inhibitor TPPU on Diclofenac-Induced Intestinal Ulcers
Sumanta Kumar Goswami et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
In vitro and in vivo metabolism of N-adamantyl substituted urea-based soluble epoxide hydrolase inhibitors
Jun-Yan Liu et al.
BIOCHEMICAL PHARMACOLOGY (2015)
14,15-Epoxyeicosatrienoic Acid Suppresses Cigarette Smoke Extract-Induced Apoptosis in Lung Epithelial Cells by Inhibiting Endoplasmic Reticulum Stress
Ganggang Yu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Epoxyeicosatrienoic Acids, Hypertension, and Kidney Injury
John D. Imig
HYPERTENSION (2015)
Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern
Annika I. Ostermann et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2015)
Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice
Todd R. Harris et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
The 2014 Bernard B. Brodie Award Lecture-Epoxide Hydrolases: Drug Metabolism to Therapeutics for Chronic Pain
Sean D. Kodani et al.
DRUG METABOLISM AND DISPOSITION (2015)
Soluble Epoxide Hydrolase Pharmacological Inhibition Ameliorates Experimental Acute Pancreatitis in Mice
Ahmed Bettaieb et al.
MOLECULAR PHARMACOLOGY (2015)
Optimized Inhibitors of Soluble Epoxide Hydrolase Improve in Vitro Target Residence Time and in Vivo Efficacy
Kin Sing Stephen Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human Health
Christophe Morisseau et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Substituted phenyl groups improve the pharmacokinetic profile and anti-inflammatory effect of urea-based soluble epoxide hydrolase inhibitors in murine models
Jun-Yan Liu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Upregulation of soluble epoxide hydrolase in proximal tubular cells mediated proteinuria-induced renal damage
Qian Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys
A. Ulu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Pharmacokinetics and Pharmacodynamics of AR9281, an Inhibitor of Soluble Epoxide Hydrolase, in Single- and Multiple-Dose Studies in Healthy Human Subjects
Dawn Chen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Discovery of Inhibitors of Soluble Epoxide Hydrolase: A Target with Multiple Potential Therapeutic Indications
Hong C. Shen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
EPOXIDES AND SOLUBLE EPOXIDE HYDROLASE IN CARDIOVASCULAR PHYSIOLOGY
John D. Imig
PHYSIOLOGICAL REVIEWS (2012)
In Vitro Glucuronidation of the Antibacterial Triclocarban and Its Oxidative Metabolites
N. H. Schebb et al.
DRUG METABOLISM AND DISPOSITION (2012)
The anti-inflammatory effects of soluble epoxide hydrolase inhibitors are independent of leukocyte recruitment
Benjamin B. Davis et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia
Sampath-Kumar Anandan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Soluble Epoxide Hydrolase Inhibitors and Heart Failure
Hong Qiu et al.
CARDIOVASCULAR THERAPEUTICS (2011)
Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance
Ayala Luria et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs
Hsing-Ju Tsai et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
1-Aryl-3-(1-acylpiperidin-4-yl)urea Inhibitors of Human and Murine Soluble Epoxide Hydrolase: Structure-Activity Relationships, Pharmacokinetics, and Reduction of Inflammatory Pain
Tristan E. Rose et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Soluble Epoxide Inhibition Is Protective Against Cerebral Ischemia via Vascular and Neural Protection
Alexis N. Simpkins et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Mammalian epoxide hydrolases in xenobiotic metabolism and signalling
Martina Decker et al.
ARCHIVES OF TOXICOLOGY (2009)
Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors
Danyan Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension
JD Imig et al.
HYPERTENSION (2005)
Distribution of soluble epoxide hydrolase and of cytochrome P4502C8, 2C9, and 2J2 in human tissues
AE Enayetallah et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2004)
In vitro metabolism of the mammalian soluble epoxide hydrolase inhibitor, 1-cyclohexyl-3-dodecyl-urea
T Watanabe et al.
DRUG METABOLISM AND DISPOSITION (2003)
Structural refinement of inhibitors of urea-based soluble epoxide hydrolases
C Morisseau et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Rapid determination of soluble epoxide hydrolase inhibitors in rat hepatic microsomes by high-performance liquid chromatography with electrospray tandem mass spectrometry
T Watanabe et al.
ANALYTICAL BIOCHEMISTRY (2001)
Share Paper
